Akso Health Group Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	14.84	14.78	2.41	13.18	6	-
Revenue	14.84	14.78	2.41	13.18	6	-
Revenue Growth (YoY)	75.55%	512.09%	-81.68%	119.69%	-	-
Cost of Revenue	14.69	15.06	2.29	11.91	5.39	-
Gross Profit	0.15	-0.28	0.12	1.27	0.61	-
Selling, General & Admin	4.97	3.64	8.76	15.54	2.67	2.03
Operating Expenses	4.97	3.64	8.76	15.54	3.06	2.09
Operating Income	-4.82	-3.92	-8.64	-14.27	-2.46	-2.09
Interest Expense	-	-	-	-	-0.8	-2.15
Currency Exchange Gain (Loss)	-0	-0	-0.59	1.14	-0.75	-
Other Non Operating Income (Expenses)	0	0.03	0.14	0.06	0	-0.05
EBT Excluding Unusual Items	-4.81	-3.89	-9.09	-13.07	-4.01	-4.29
Impairment of Goodwill	-41.37	-41.37	-	-	-	-
Asset Writedown	-121.01	-121.01	-	-	-	-
Pretax Income	-167.2	-166.27	-9.09	-13.07	-4.01	-4.29
Income Tax Expense	-30.98	-30.8	0.02	0.02	0.09	-
Earnings From Continuing Operations	-136.22	-135.47	-9.12	-13.08	-4.1	-4.29
Earnings From Discontinued Operations	-	-	-0.4	11.84	-12.75	-30.53
Net Income to Company	-136.22	-135.47	-9.52	-1.25	-16.85	-34.83
Minority Interest in Earnings	0.55	0.49	0.06	-0.11	-0	-
Net Income	-135.67	-134.98	-9.46	-1.36	-16.85	-34.83
Net Income to Common	-135.67	-134.98	-9.46	-1.36	-16.85	-34.83
Shares Outstanding (Basic)	463	285	47	23	20	16
Shares Outstanding (Diluted)	463	285	47	23	20	16
Shares Change (YoY)	204.20%	504.37%	106.30%	15.07%	22.06%	0.17%
EPS (Basic)	-0.29	-0.47	-0.20	-0.06	-0.85	-2.14
EPS (Diluted)	-0.30	-0.48	-0.22	-0.08	-0.85	-2.15
Free Cash Flow	-168.43	1.02	1.35	-3.25	-8.63	10.06
Free Cash Flow Per Share	-0.36	0.00	0.03	-0.14	-0.43	0.62
Gross Margin	1.00%	-1.91%	5.06%	9.63%	10.09%	-
Operating Margin	-32.47%	-26.55%	-357.78%	-108.23%	-40.94%	-
Profit Margin	-914.06%	-913.38%	-391.77%	-10.32%	-280.85%	-
Free Cash Flow Margin	-1134.83%	6.92%	55.97%	-24.68%	-143.81%	-
EBITDA	-1.46	-1.77	-	-14.25	-2.44	-2.07
EBITDA Margin	-9.85%	-12.00%	-	-108.09%	-40.63%	-
D&A For EBITDA	3.36	2.15	-	0.02	0.02	0.02
EBIT	-4.82	-3.92	-8.64	-14.27	-2.46	-2.09
EBIT Margin	-32.47%	-26.55%	-	-108.23%	-40.94%	-
Revenue as Reported	14.84	14.78	2.41	13.18	6	-
Advertising Expenses	-	-	0.17	0.01	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q